Search
for
Sort by
Research 691–720 of 1000+
- Ophthalmic manifestations of Demodex spp. infection – what should a dermatologist know?
- Estimation of renin and D-dimer levels in women with polycystic ovary disease with or without coronavirus infection
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- Development and Validation of A C57BL/6 Mouse Model of Androgenetic Alopecia Through Testosterone Propionate Induction
- ANTIBACTERIAL POTENTIALS OF ALOE BARBADENSIS MILLER AND CITRUS LIMON PLANT EXTRACTS AGAINST SKIN INFECTING PROPIONIBACTERIUM ACNES: BOTH IN-VITRO AND IN-VIVO ATTEMPTS
- A Preliminary Study on Application of Vibrating Device Instead of Topical Anaesthetic Gel During Injection of Local Anaesthesia
- 571 Role of observation for excisionally biopsied moderately dysplastic nevi with positive histologic margins and risk of development of future melanoma
- Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction
- Neuroactive Steroids and Ethanol Exposure: Relevance to Ethanol Sensitivity and Alcohol Use Disorders Risk
- Valproic acid boosts hair follicle stem cell resilience to oxygen-glucose deprivation through autophagy induction and AKT/mTOR suppression
- Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection
- Long COVID-19 Effects (Chronic Covid-19 syndrome) in Nepalese Cohort recovered from SARS-CoV-2 infection
- Trichoscopic Features, Clinical Correlates, and Risk Prediction in Female Pattern Hair Loss: A Retrospective Case-Control Study
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Hair, Hormones, and High-Risk Prostate Cancer
- Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Depression risk of 5-alpha reductase inhibitors: A systematic review and meta-analysis with a focus on comparator groups
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- Risk factors for diabetic foot ulcers mortality and novel negative pressure combined with platelet-rich plasma therapy in the treatment of diabetic foot ulcers
- Risk factors and early preventive measures for long COVID in non-hospitalized patients: analysis of a large cohort in the United Arab Emirates
- A case of chronic kidney disease patient with rapid deterioration of renal function, hair loss, and spontaneous resolution of facial warts after COVID‐19 infection
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Human Hair as a Testing Substrate in the Era of Precision Medicine: Potential Role of ‘Omics-Based Approaches
- The effect of canakinumab on clinical outcomes in patients with COVID-19: A meta-analysis
- Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis
- Acne keloidalis nuchae: prevalence, impact, and management challenges